M Chimienti

719 total citations
37 papers, 506 citations indexed

About

M Chimienti is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, M Chimienti has authored 37 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 12 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Surgery. Recurrent topics in M Chimienti's work include Cardiac Arrhythmias and Treatments (23 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Cardiac Imaging and Diagnostics (12 papers). M Chimienti is often cited by papers focused on Cardiac Arrhythmias and Treatments (23 papers), Cardiac electrophysiology and arrhythmias (15 papers) and Cardiac Imaging and Diagnostics (12 papers). M Chimienti collaborates with scholars based in Italy, Canada and United States. M Chimienti's co-authors include J. A. Salerno, Mario Previtali, Gianluigi Casadei, Antonio Medici, C Panciroli, Giuśeppe Specchia, Catherine Klersy, Luigi Tavazzi, Michael Cullen and M. Previtali and has published in prestigious journals such as Journal of the American College of Cardiology, Annals of the New York Academy of Sciences and European Heart Journal.

In The Last Decade

M Chimienti

33 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Chimienti Italy 12 448 191 66 46 32 37 506
Howard R. Horn United States 6 336 0.8× 134 0.7× 77 1.2× 22 0.5× 21 0.7× 9 420
D S Thompson United Kingdom 12 430 1.0× 89 0.5× 103 1.6× 35 0.8× 46 1.4× 17 525
F Crea Italy 7 313 0.7× 241 1.3× 98 1.5× 11 0.2× 17 0.5× 12 366
B N Singh United States 9 445 1.0× 218 1.1× 98 1.5× 33 0.7× 31 1.0× 10 521
Krister Arnman Sweden 8 668 1.5× 75 0.4× 88 1.3× 25 0.5× 29 0.9× 12 743
Angas Hamer Australia 16 903 2.0× 63 0.3× 107 1.6× 35 0.8× 79 2.5× 40 986
Robert H. Heissenbuttel United States 8 449 1.0× 67 0.4× 51 0.8× 52 1.1× 117 3.7× 9 522
Marc D. Meissner United States 12 927 2.1× 91 0.5× 183 2.8× 26 0.6× 51 1.6× 22 979
Ravinder M. Narang United States 6 249 0.6× 88 0.5× 77 1.2× 10 0.2× 26 0.8× 10 316
J G Murtagh United Kingdom 12 252 0.6× 59 0.3× 107 1.6× 26 0.6× 18 0.6× 21 346

Countries citing papers authored by M Chimienti

Since Specialization
Citations

This map shows the geographic impact of M Chimienti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Chimienti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Chimienti more than expected).

Fields of papers citing papers by M Chimienti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Chimienti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Chimienti. The network helps show where M Chimienti may publish in the future.

Co-authorship network of co-authors of M Chimienti

This figure shows the co-authorship network connecting the top 25 collaborators of M Chimienti. A scholar is included among the top collaborators of M Chimienti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Chimienti. M Chimienti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chimienti, M, Michael Cullen, & Gianluigi Casadei. (1995). Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. European Heart Journal. 16(12). 1943–1951. 46 indexed citations
3.
Chimienti, M, Enrico Pusineri, Mario Regazzi, et al.. (1994). Once daily felodipine in preventing ergonovine-induced myocardial ischaemia in Prinzmetal's variant angina. European Heart Journal. 15(3). 389–393. 4 indexed citations
4.
Klersy, Catherine, et al.. (1993). Factors that predict spontaneous remission of ectopic atrial tachycardia. European Heart Journal. 14(12). 1654–1656. 18 indexed citations
5.
Chimienti, M, et al.. (1992). Comparison of Isoproterenol and Exercise Tests in Asymptomatic Subjects with Wolff‐Parkinson‐White Syndrome. Pacing and Clinical Electrophysiology. 15(8). 1158–1166. 8 indexed citations
6.
Klersy, Catherine, et al.. (1991). Influence of surgical revascularization on late potentials in patients with myocardial infarction. Journal of the American College of Cardiology. 17(2). A304–A304. 1 indexed citations
7.
Chimienti, M, et al.. (1989). Electrophysiologic and clinical effects of oral encainide in paroxysmal atrioventricular node reentrant tachycardia. Journal of the American College of Cardiology. 14(4). 992–998. 5 indexed citations
8.
Previtali, Mario, Diego Ardissino, Paolo Barberis, et al.. (1989). Hyperventilation and ergonovine tests in prinzmetal's variant angina pectoris in men. The American Journal of Cardiology. 63(1). 17–20. 56 indexed citations
9.
Previtali, Mario, C Panciroli, Roberto De Ponti, et al.. (1989). Time-related decrease in sensitivity to ergonovine in patients with variant angina. American Heart Journal. 117(1). 92–99. 20 indexed citations
10.
Chimienti, M, Mario Regazzi, Maria Teresa La Rovere, et al.. (1988). Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration. Cardiovascular Drugs and Therapy. 2(5). 679–686. 6 indexed citations
11.
Klersy, Catherine, et al.. (1988). [Intravenous flecainide in Wolff-Parkinson-White syndrome: a test for evaluation of the refractory period of the anomalous pathway. Comparison with ajmaline].. PubMed. 33(5). 531–5. 1 indexed citations
12.
Chimienti, M, J. A. Salerno, Catherine Klersy, et al.. (1987). Electrophysiologic and clinical effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation. European Heart Journal. 8(3). 282–290. 7 indexed citations
13.
Chimienti, M, et al.. (1986). When are arrhythmias and conduction disturbances markers of myocardial ischemia at rest?. PubMed. Suppl A. 63A–66A.
14.
Chimienti, M, et al.. (1985). Valore predittivo del test all'ajmalina nella valutazione del periodo refrattario effettivo della via accessoria e sua riproducibilita' in pazienti con sindrome di Wolff-Parkinson-White.. IrInSubria (University of Insubria). 30. 16–16.
15.
Salerno, J. A., et al.. (1984). VASOSPASM AND VENTRICULAR ARRHYTHMIAS. Annals of the New York Academy of Sciences. 427(1). 222–233. 12 indexed citations
16.
Chimienti, M, et al.. (1982). Acute verapamil poisoning: Successful treatment with epinephrine. Clinical Cardiology. 5(3). 219–222. 38 indexed citations
17.
Rondanelli, R, et al.. (1982). The bioavailability and kinetics of dihydroquinidine in patients with heart disease.. PubMed. 20(5). 212–8. 3 indexed citations
19.
Tavazzi, Luigi, et al.. (1979). Paroxysmal atrioventricular tachycardia involving an anomalous pathway with antegrade unidirectional block.. PubMed. 9(4). 285–305. 2 indexed citations
20.
Tavazzi, Luigi, et al.. (1978). [Electrophysiological mechanisms of paroxysmal atrio-ventricular block].. PubMed. 8(8). 892–901. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026